Compare Domino's Pizza, Inc. (DPZ) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance

Domino's Pizza, Inc.Trade

Royalty Pharma plc Class A Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Domino's Pizza, Inc. vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Domino's Pizza, Inc. trades at $309.23 (market cap $10.21B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.88 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 2.5× Domino's Pizza, Inc.'s market cap, and Domino's Pizza, Inc. pays the higher dividend (2.58%). Which is the better fit depends on your goals — on Pluang, investors hold Domino's Pizza, Inc. for 106 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.

	DPZ	RPRX
Market Cap	$10.21B	$25.27B
Volume	916,737	3,671,183
Sector	Consumer Cyclical	Health
52-Week High	$438.42	$63.96
52-Week Low	$282.89	$35.44
Typical Hold Time	106 Days	1 Days
Enterprise Value	$15.17B	$32.50B
Dividend Yield	2.58%	1.66%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Domino's Pizza, Inc.

DPZ trades at $309.36, up 2.07% today, amid a mixed technical and fundamental backdrop. The stock shows a bullish overall technical signal but has missed earnings estimates for three consecutive quarters. Revenue and net income have grown steadily, reaching $4.94 billion and $601.70 million in 2025, respectively, though profit margins are under slight pressure. Recent news highlights store closures and dividend stability concerns alongside promotional initiatives.

The outlook is cautiously optimistic, supported by analyst consensus but tempered by high debt and recent earnings misses. Investment opportunity lies in potential valuation expansion toward the $373 price target, while key risks include elevated leverage, competitive pressures, and execution challenges in maintaining growth.

Royalty Pharma plc Class A Ordinary Shares

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DPZ

Domino's Pizza Q3 earnings expected to rise slightly with focus on promo impactTony Dante · 1 day agoNeutral Domino’s outperforms Yum Brands in dividend growth but lags in share price stability for retirees.24/7 Wall Street · 2 days agoNeutral Domino's offers 50% off all pizzas from Oct 5-11 for National Pizza MonthPRNewsWire · 4 days agoBullish View details →

RPRX

Royalty Pharma to release Q3 2026 earnings on Nov 4 with live webcast and call.GlobeNewsWire · 13 hours agoNeutral View details →

About Domino's Pizza, Inc.

Domino's is a restaurant operator and franchiser with nearly 19,000 global stores across more than 90 international markets at the end of 2021. The firm generates revenue through the sales of pizza, wings, salads, and sandwiches at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's U.S. and Canadian restaurants. With roughly $17.7 billion in 2021 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Papa John's, and Little Caesars.

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.